Showing results (321-330 of 335) with videos related to

Sort By:
Pageof 34
The Lancet. Oncology|November 12, 2021
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trialSjoukje F Oosting, Astrid A M van der Veldt, Corine H GeurtsvanKessel, et al.
Nature Communications|November 24, 2021
Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the NetherlandsLu Lu, Reina S Sikkema, Francisca C Velkers, et al.
Transplantation|November 10, 2021
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, Frederike J Bemelman, A Lianne Messchendorp, et al.
The Lancet. Infectious Diseases|April 23, 2023
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trialNgoc H Tan, Daryl Geers, Roos S G Sablerolles, et al.
The Journal of Infection|January 10, 2026
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccinationDaryl Geers, Muriel Aguilar-Bretones, Luca M Zaeck, et al.
Nature Communications|August 23, 2025
One Health approach uncovers emergence and dynamics of Usutu and West Nile viruses in the NetherlandsEmmanuelle Münger, Nnomzie C Atama, Jurrian van Irsel, et al.
The Lancet Regional Health. Europe|August 16, 2023
Decision-support tools to build climate resilience against emerging infectious diseases in Europe and beyondJoacim Rocklöv, Jan C Semenza, Shouro Dasgupta, et al.
The Lancet. Infectious Diseases|July 6, 2020
COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional studyReina S Sikkema, Suzan D Pas, David F Nieuwenhuijse, et al.
Nature Communications|January 12, 2021
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)Jeroen J A van Kampen, David A M C van de Vijver, Pieter L A Fraaij, et al.
Nature Communications|May 28, 2021
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infectionArvind Gharbharan, Carlijn C E Jordans, Corine GeurtsvanKessel, et al.
Pageof 34